Viela Bio Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$250M
Industry:Biotech
Founded:2018
Lead Investor(s):Boyu Capital, 6 Dimensions Capital

City Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Viela Bio's estimated annual revenue is currently $23.4M per year.
  • Viela Bio received $250.0M in venture funding in March 2018.
  • Viela Bio's estimated revenue per employee is $155,000
  • Viela Bio's total funding is $250M.

Employee Data

  • Viela Bio has 151 Employees.
  • Viela Bio grew their employee count by 59% last year.
  • Viela Bio currently has 7 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Intralytix
$4.7M30N/AN/AN/A
OriGene Technol...
$15.7M101-4%N/AN/A
American Gene T...
$4.7M30N/AN/AN/A
Profectus Biosc...
$3.9M25N/AN/AN/A
BioIT Solutions
$1.9M12N/AN/AN/A
BioReliance Cor...
$126.3M815N/AN/AN/A
Aziyo Biologics
$25.4M1644%N/AN/A
Osiris Therapeu...
N/A334N/AN/AN/A
Northwest Bioth...
N/A16N/AN/AN/A
Stemgent
$2.5M16N/AN/AN/A
Missing a competitor? Contribute!?
Submit

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company's portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland. Learn more at www.vielabio.com

keywords:N/A

151

Number of Employees

$23.4M

Revenue (est)

7

Current Jobs

59%

Employee Growth %

$250M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Mike ZorzyRegional Business Director
Jim WalkerRegional Business Director, West
Bill LitzenbergAssociate Director, Clinical Data Management
Steven SahebManager, Business Development
Deborah GirmaClinical Project Manager
Michele GunsiorPrincipal Scientist
Dewei SheSenior Director, Head of Data Sciences at Viela Bio
Jodi KarnellAssociate Director
Maryam MazaheriAssociate Director of Technical
Matthew DicksonDirector, Head of CMC Partnership at Viela Bio

Viela Bio News

07-Sep-19 - 5 things to know ahead of Viela Bio’s planned $150M IPO

It's a pivotal moment for the MedImmune spinout, which has put the fate of its first prospective product in regulators' hands.

31-Aug-19 - Viela Bio clears another hurdle to get rare disease drug to market

Gaithersburg's Viela Bio Inc. has crossed another milepost in its race to get its first drug to market. The fast-moving biotech has submitted its ...

31-Aug-19 - Viela Bio Becomes Latest Biotech Intent on Going Public with $150M Offering

August 29, 2019. Viela Bio, the AstraZeneca spin-off biotech, has captured the attention of industry insiders since their $250M Series A investment that launched ...

Viela Bio Funding

DateAmountRoundLead InvestorsReference
2018-03-01$250.0MUndisclosedBoyu CapitalArticle